Increasing demand for non-invasive biomarkers to catapult growth in the exosome diagnostic and therapeutic market. The market size is expected to increase from USD 88.56 million in 2024 to USD 211.6 million by 2034, at a 9.10% CAGR.
Attributes | Key Insights |
---|---|
Estimated Exosomes Diagnostic and Therapeutic Market Size (2024E) | USD 88.56 million |
Projected Exosomes Diagnostic and Therapeutic Market Valuation (2034F) | USD 211.6 million |
Value-based CAGR (2024 to 2034) | 9.10% |
The healthcare sector is facing pressure to reduce the prices of healthcare services to increase their accessibility among the rising patient population. In this regard, laboratories are adopting solutions that are integrated with informatics. This helps boost productivity with the help of available resources.
Manufacturers are taking an opportunistic approach by offering such healthcare facilities with additional services and support in terms of diagnostic test products. Consequently, contributes to market growth.
Key players are also capitalizing on the growing demand for non-invasive tests to diagnose cancer. For this, they continue to maintain partnerships with academic institutes to develop novel non-invasive diagnostics.
Leading Application | Diagnostics |
---|---|
Value Share (2024) | 68.0% |
Based on application, the exosome-based diagnostics segment acquired a massive value share of 68% in 2023. Significant use of exosomes for diagnostic purposes can be attributed to their effective delivery of specific disease cells like nucleic acids and proteins. Exosome diagnostic tests are presently being developed for several diseases like infectious diseases, cancer, and neurological disorders.
Leading Product Type | Instruments |
---|---|
Value Share (2024) | 25.0% |
By product type, the instruments segment accounts for a prominent share of 25% in the exosomes diagnostic and therapeutic market. The segment is driven by rapid advancements in research and development activities in the healthcare sector. Growth in the count of manufacturers providing instruments for diagnostic and therapeutic is also propelling the segment expansion.
Countries | Forecast CAGR (2024 to 2034) |
---|---|
The United States | 4.50% |
Canada | 5.0% |
Germany | 3.80% |
China | 10.0% |
India | 9.50% |
Market players are exploiting the potential for the exosome diagnostic and therapeutic industry in the United States, which is estimated to grow at 4.5% CAGR over the forecast period. Exosomes have been receiving significant traction over the past few years due to their remarkable therapeutic possibilities.
They can be harnessed for focused delivery of therapeutic agents, like nucleic acids, proteins, and pharmaceuticals, nucleic acids, throughout biological barriers. This attribute holds a lot of potential in precision medicine applications, especially in cancer therapy.
Numerous cutting-edge technologies and the latest strategies have been developed to harness the capability of exosomes to enhance the efficiency and precision of cancer detection. These approaches can revolutionize cancer diagnostics, offering non-invasive, more precise, and early detection methods.
Liquid biopsies are one such disruptive strategy in cancer treatment, which uses non-invasive collection and investigation of exosomes from body fluids like urine, blood, and saliva.
The rapid increase in cancer patients and surging funding for cancer-related research are expected to continue supporting the exosome diagnostic and therapeutic industry in the United States.
Adoption of exosomes diagnostic and therapeutic in Canada is projected to surge at a CAGR of 5% through 2034. Growth of this industry is increasing as researchers are trying to understand the connection between kidney function and disorders and urinary exosomes since exosomes carry cargo across kidney cells.
The availability, non-invasive nature, and ease of sample collection of urinary exosomes make them remarkable. Non-invasive exosomes offer a cost-effective way to uncover disease causes and therapeutic targets owing to their prognostic and diagnostic sensitivity. Additionally, non-invasive biomarkers have more patient and clinical adoption than their invasive counterparts.
Conveniently distributable and cost-effective distributable urinary indicators are clinically accessible. These factors contribute to the growth of the exosomes diagnostic and therapeutic market.
The scope of exosomes diagnostic and therapeutic in Germany is estimated to expand at a CAGR of 3.80% over the next 10 years. The industry is expected to be propelled by the increasing count of research activities with a focus on applications of exosomes to access the therapeutic effects of stem cells within the country.
Growing demand for advanced diagnostic assays as well as the increasing incidence of cancer in Germany are contributing to exosomes diagnostic and therapeutic market growth. Certain common factors that are compelling growth in the industry include advancements in healthcare systems and surging funding for research and development in Germany.
Investments in the Indian market are projected to rise at a CAGR of 9.5% in the following decade. Increasing cases of diseases like infectious disorders, cancer, and neurological diseases in India are raising the demand for more effective treatment and diagnostic tools offered by exosomes.
Ongoing technological advancements like proteomic analysis and high-throughput techniques are facilitating the characterization and identification of exosomes. Along with this, technological progress is helping in the development of diagnostic therapies and tools based on exosomes.
Surging investments from government agencies, private investors, and pharmaceutical firms are promoting research and growth in exosome diagnostics and therapeutics. With improving regulatory acceptance for exosome-based products, the market is set for significant expansion.
Demand for exosome diagnostic and therapeutic in China is expected to rise at a CAGR of 10% over the forecast period. The market is driven by an increase in clinically researched and perceived applications of exosomes as smart nano-platforms for therapy and diagnosis in the country. Additionally, market players in China are increasing their efforts to exhibit the utility of exosomes in non-invasive testing to accelerate its adoption.
The exosome diagnostic and therapeutic industry is experiencing a high level of competition, thanks to the growing count of companies manufacturing exosome-based products. All known companies in the market are covered below. Along with the companies, the technology that they are working on is also described. The following companies may or may not be working with any regulatory agencies, however, many of them do.
AcouSort AB
It is a Swedish firm that is introducing a revolutionary acoustofluidic technology and working on exosome-based diagnostics. The European Innovation Council (EIC) rewarded AcouSort and its project partners with a total of USD 2.5 million to create acoustofluidic thin-film actuated chip to separate exosomes from blood.
Aethlon Medical, Inc.
It is a United States-based company that focuses on addressing the unmet requirements in the global health and biodefense industry. The firm began its tumor-derived exosome research when the medical community held a view that exosomes are cellular debris.
Fast-forward to the present, a therapeutic to attend to tumor-derived exosomes presents a significant gap in cancer care. Aethlon has shown that Hemopurifier®’s affinity mechanism can detect tumor-derived exosomes behind various forms of cancer, like ovarian, breast, and metastatic melanoma.
AGC Biologics
AGC Biologics came into a service agreement with Japan’s Jikei University in April 2023. This agreement states that AGC Biologics is going to assume a feasibility study and technology transfer for a drug to cure idiopathic pulmonary fibrosis (IPF). Specifically, the ACG scientists are going to focus on recognizing the viability of developing a sample for an exosome-based treatment.
Aruna Bio
The company is leveraging the natural abilities of neural exosomes to pass the blood-brain barrier and elevate the body’s anti-inflammatory, protective, and self-repair mechanisms for neurodegenerative disorders treatment.
Latest Developments in the Exosomes Diagnostic and Therapeutic Market
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Component, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Component, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 17: Global Market Attractiveness by Component, 2024 to 2034
Figure 18: Global Market Attractiveness by Application, 2024 to 2034
Figure 19: Global Market Attractiveness by End User, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Component, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 37: North America Market Attractiveness by Component, 2024 to 2034
Figure 38: North America Market Attractiveness by Application, 2024 to 2034
Figure 39: North America Market Attractiveness by End User, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Component, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Component, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 59: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Component, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Component, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Component, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Component, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Component, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Component, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Component, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Component, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 139: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Component, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Component, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Component, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Component, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Component, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
For the year 2024, the exosomes diagnostic and therapeutic industry is estimated to be valued at USD 88.56 million.
The adoption rate of exosomes diagnostic and therapeutic is calculated to be around 9.10% for the forecast period.
The market revenue is expected to shoot up to USD 211.6 million by 2034.
The diagnostics segment grabs a hefty share within the exosomes diagnostic and therapeutic industry.
China is expected to register a significant growth rate in the exosomes diagnostic and therapeutic industry.
Anjarium Biosciences AG, Aruna Bio, and Brexogen are influential players in the exosome diagnostic and therapeutic industry.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.